Director, Media & Public Relations
Company: Summit Therapeutics Sub, Inc.
Location: Miami
Posted on: February 18, 2026
|
|
|
Job Description:
Job Description Job Description Location: Onsite (Palo Alto, CA
or Miami, FL) About Summit: Summit Therapeutics Inc. is a
biopharmaceutical oncology company with a mission focused on
improving quality of life, increasing potential duration of life,
and resolving serious unmet medical needs. At Summit, we believe in
building a team of world class professionals who are passionate
about this mission, and it is our people who drive this mission to
reality. Summit’s core values include integrity, passion for
excellence, purposeful urgency, collaboration, and our commitment
to people. Our employees are truly the heart and soul of our
culture, and they are invaluable in shaping our journey toward
excellence. Summit’s team is inspired to touch and help change
lives through Summit’s clinical studies in the field of oncology.
Summit has multiple global Phase 3 clinical studies, including:
Non-small Cell Lung Cancer (NSCLC) HARMONi: Phase 3 clinical study
which was intended to evaluate ivonescimab combined with
chemotherapy compared to placebo plus chemotherapy in patients with
EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who
were previously treated with a 3rd generation EGFR TKI. HARMONi-3:
Phase 3 clinical study which is intended to evaluate ivonescimab
combined with chemotherapy compared to pembrolizumab combined with
chemotherapy in patients with first-line metastatic NSCLC.
HARMONi-7: Phase 3 clinical study which is intended to evaluate
ivonescimab monotherapy compared to pembrolizumab monotherapy in
patients with first-line metastatic NSCLC. Colorectal Cancer (CRC)
HARMONi-GI3: Phase 3 clinical study intended to evaluate
ivonescimab in combination with chemotherapy compared with
bevacizumab plus chemotherapy. Ivonescimab is an investigational
therapy not presently approved by any regulatory authority other
than China’s National Medical Products Administration (NMPA).
Summit is headquartered in Miami, Florida, and has additional
offices in California, New Jersey, the UK, and Ireland. Overview of
Role: Lead enterprise-level media relations and public-relations
strategy for a fast-growing biotech. You will serve as a primary
company spokesperson, architect integrated earned-media campaigns,
and manage issues across discovery, clinical, regulatory, and
commercial milestones. You’ll partner tightly with Executive
Leadership, Regulatory/Medical Affairs, Clinical, and IR, to
develop and advance corporate and product reputation. Role and
Responsibilities: Own global media strategy: Build and execute
proactive media plans (top-tier, trade, local) aligned to pipeline
and corporate calendar; secure coverage for data readouts,
regulatory filings/approvals, financings, collaborations, and
leadership POVs. Spokesperson & press office: Serve as day-to-day
media contact; prep executives; draft/QA press materials (Q&As,
op-eds, media briefs) and oversee measurement. Issues
communications: Lead rapid response for any potential negative
feedback or public communication; run scenario planning and
war-room protocols. Data & conference moments: Orchestrate
scientific congress communications (e.g., AACR, ASCO, ESMO), and
coordinate with IR regarding press releases, earnings releases, and
other disclosures. Thought leadership: Build exec platforms across
earned/owned/speaking ; manage ghostwriting and social
amplification (in partnership with Digital/IR). Agency & budget
leadership: Select and manage PR agencies; negotiate SOWs; own
measurement/KPIs and quarterly dashboards. Policy & advocacy
alignment: Coordinate with Patient Advocacy to ensure media
narratives support access and policy goals; anticipate external
risks. All other duties as assigned Experience, Education and
Specialized Knowledge and Skills: Experience: Minimum of 10 years
in media relations/public relations/corporate communications,
including significant time in biopharma/biotech or a healthcare PR
agency supporting biopharma. Domain fluency: Comfort translating
preclinical/clinical/regulatory topics; familiarity with GxP,
FDA/EMA milestones, payer dynamics, and scientific conferences.
Proven spokesperson: Track record landing tier-one coverage and
managing high-stakes issues. Leadership & collaboration: Executive
presence; calm under pressure; excellent judgment; deft
cross-functional coordination. Writing & storytelling: Crisp
executive writing; strong news sense; data-driven measurement
mindset. Bachelor’s degree in Communications, Public Relations,
Life Sciences, Journalism, or related field required. Graduate
degree preferred The pay range for this role is $184,000-$230,000
annually. Actual compensation packages are based on several factors
that are unique to each candidate, including but not limited to
skill set, depth of experience, certifications, and specific work
location. This may be different in other locations due to
differences in the cost of labor. The total compensation package
for this position may also include bonus, stock, benefits and/or
other applicable variable compensation. Summit does not accept
referrals from employment businesses and/or employment agencies in
respect of the vacancies posted on this site. All employment
businesses/agencies are required to contact Summit’s Talent
Acquisition team at recruiting@smmttx.com to obtain prior written
authorization before referring any candidates to Summit.
Keywords: Summit Therapeutics Sub, Inc., Doral , Director, Media & Public Relations, PR / Public Relations , Miami, Florida